Propel Bio Management, LLC Ardelyx, Inc. Transaction History
Propel Bio Management, LLC
- $154 Billion
- Q2 2024
A detailed history of Propel Bio Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 924,583 shares of ARDX stock, worth $5.33 Million. This represents 4.44% of its overall portfolio holdings.
Number of Shares
924,583
Previous 594,174
55.61%
Holding current value
$5.33 Million
Previous $4.34 Billion
57.95%
% of portfolio
4.44%
Previous 2.52%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
209Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$150 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$78.8 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$69 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$39.8 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $892M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...